Amundi’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $32.1M | Buy |
|
|||||
|
2025
Q2 | $28.4M | Sell |
|
|||||
|
2025
Q1 | $23.8M | Sell |
|
|||||
|
2024
Q4 | $36.3M | Sell |
|
|||||
|
2024
Q3 | $73.3M | Buy |
|
|||||
|
2024
Q2 | $54.1M | Buy |
|
|||||
|
2024
Q1 | $47.9M | Buy |
|
|||||
|
2023
Q4 | $45.5M | Buy |
|
|||||
|
2023
Q3 | $34.5M | Sell |
|
|||||
|
2023
Q2 | $112M | Sell |
|
|||||
|
2023
Q1 | $125M | Buy |
|
|||||
|
2022
Q4 | $102M | Buy |
|
|||||
|
2022
Q3 | $88.7M | Buy |
|
|||||
|
2022
Q2 | $6.15M | Sell |
|
|||||
|
2022
Q1 | $6.49M | Sell |
|
|||||
|
2021
Q4 | $11M | Buy |
|
|||||
|
2021
Q3 | $13.2M | Buy |
|
|||||
|
2021
Q2 | $11.9M | Buy |
|